Serum thromboxane B2 after intravenous administration of talinolol and propranolol in healthy subjects.
Sziegoleit
W
W
Department of Pharmacology and Toxicology, Martin Luther University, Halle-Wittenberg.
Block
H U
HU
Fahr
A
A
Mest
H J
HJ
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D002849:Chromatography, Gas; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007275:Injections, Intravenous; D011412:Propanolamines / Q000008:administration & dosage / Q000494:pharmacology*; D011433:Propranolol / Q000008:administration & dosage / Q000494:pharmacology*; D012016:Reference Values; D013929:Thromboxane B2 / Q000097:blood*
D000319:Adrenergic beta-Antagonists; D011412:Propanolamines; C011550:talinolol; D013929:Thromboxane B2; D011433:Propranolol